Indivior Can't Duck Opioid Marketing Fraud Indictment

Law360 (November 15, 2019, 7:47 PM EST) -- Indivior can’t shed an indictment alleging it engaged in fraudulent opioid marketing just because prosecutors gave a grand jury evidence about a doctor’s unrelated fraud convictions, a Virginia federal judge has ruled, saying the company’s concerns about guilt by association were overstated.

U.S. District Judge James P. Jones said Thursday that the U.S. Department of Justice didn't present inadmissible evidence by briefly referencing a doctor's health care fraud convictions in an indictment that alleged Indivior orchestrated a nationwide scheme to falsely promote Suboxone Film as a more child-proof and less addictive version of the opioid addiction drug's tablet form.

The DOJ’s...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS